- Home
- IMMX vs OPHC Comparison
IMMX vs OPHC Comparison
Compare IMMX & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- OPHC
- Stock Information
- Founded
- IMMX 2014
- OPHC 2000
- Country
- IMMX United States
- OPHC United States
- Employees
- IMMX N/A
- OPHC 60
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- OPHC Major Banks
- Sector
- IMMX Health Care
- OPHC Finance
- Exchange
- IMMX Nasdaq
- OPHC Nasdaq
- Market Cap
- IMMX 46.8M
- OPHC 49.0M
- IPO Year
- IMMX 2021
- OPHC N/A
- Fundamental
- Price
- IMMX $1.67
- OPHC $4.85
- Analyst Decision
- IMMX Strong Buy
- OPHC Hold
- Analyst Count
- IMMX 1
- OPHC 1
- Target Price
- IMMX $7.00
- OPHC $5.25
- AVG Volume (30 Days)
- IMMX 89.1K
- OPHC 96.1K
- Earning Date
- IMMX 11-12-2024
- OPHC 11-08-2024
- Dividend Yield
- IMMX N/A
- OPHC N/A
- EPS Growth
- IMMX N/A
- OPHC 78.77
- EPS
- IMMX N/A
- OPHC 1.32
- Revenue
- IMMX N/A
- OPHC $34,509,000.00
- Revenue This Year
- IMMX N/A
- OPHC N/A
- Revenue Next Year
- IMMX $200.00
- OPHC N/A
- P/E Ratio
- IMMX N/A
- OPHC $3.75
- Revenue Growth
- IMMX N/A
- OPHC 66.69
- 52 Week Low
- IMMX $1.26
- OPHC $3.27
- 52 Week High
- IMMX $7.75
- OPHC $5.90
- Technical
- Relative Strength Index (RSI)
- IMMX 50.69
- OPHC 49.21
- Support Level
- IMMX $1.65
- OPHC $4.75
- Resistance Level
- IMMX $1.93
- OPHC $5.22
- Average True Range (ATR)
- IMMX 0.16
- OPHC 0.28
- MACD
- IMMX 0.01
- OPHC -0.02
- Stochastic Oscillator
- IMMX 42.55
- OPHC 17.60
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.